Stockreport
IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Akorn, Inc. and Encourages Investors With Losses In Excess of $100,000 to C...
US:NASDAQ Investor Relations: investors.akorn.com
| IMPACT SNAPSHOT | EVENT TIME: | AKRX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
AKRX alerts
AKRX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKRX alerts
High impacting AKORN news events
Weekly update
A roundup of the hottest topics
AKRX
NEWS
NEWS
- Akorn, Inc. (NASDAQ: AKRX) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating.[MarketBeat]
- Akorn, Inc. (NASDAQ: AKRX) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating.[MarketBeat]
- Akorn, Inc. (NASDAQ: AKRX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $16.00 price target on the stock.[MarketBeat]
- Akorn, Inc. (NASDAQ: AKRX) had its "buy" rating re-affirmed by analysts at Deutsche Bank AG.[MarketBeat]
- Fed. Circuit upholds decision canceling claims in Durezol eyedrops patent [Reuters][Reuters]
- More
AKRX
SEC Filings
SEC Filings
- 9/7/18 - Form 4
- 9/7/18 - Form 4
- 8/1/18 - Form 8-K
- AKRX's page on the SEC website
- More